Skip to main content
Watch Insiders
Market intelligence
EVGNSector not reported

Evogene Ltd insider activity

In the last 90 days, 1 corporate insider purchased $692,100 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$692,100
Corporate buyers
1
Latest transaction
Aug 11, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 11, 2026Leon RecanatiCorporate insiderOpen Market Purchase460,000$0.64$292,100
Aug 4, 2026Leon RecanatiCorporate insiderOpen Market Purchase800,000$0.50$400,000
Jun 4, 2026Gabi TarcicChief Development OfficerOpen Market Purchase1,129$0.60$677.40